The SIS, which incorporates serum albumin and LMR to reflect systemic inflammation and nutritional status, was first introduced as a prognostic tool in colorectal cancer and clear cell renal carcinoma [27,28]. The gene discussed is ALB; the disease is clear cell renal carcinoma.